Affordable Access

Mucoid impaction: an unusual form of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.

Authors
  • Cakir, E
  • Uyan, Z S
  • Ersu, R Hamutcu
  • Karadag, B
  • Karakoc, F
  • Dagli, E
Type
Published Article
Journal
Pediatric pulmonology
Publication Date
Nov 01, 2006
Volume
41
Issue
11
Pages
1103–1107
Identifiers
PMID: 16998923
Source
Medline
License
Unknown

Abstract

We reported a child with cystic fibrosis (CF) who developed mucoid impaction related to allergic bronchopulmonary aspergillosis (ABPA). This is the first reported case of mucoid impaction related to ABPA in CF described to date in the literature. The case was successfully treated by corticosteroids and itraconazole therapy, but relapsed 6 months later. During exacerbation therapy, cataract formation complicated the corticosteroid treatment. We want to emphasize that 6-months therapy may be inadequate for the treatment of ABPA, and it is important to monitor for possible complications of corticosteroids therapy.

Report this publication

Statistics

Seen <100 times